Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Advanced Materials Regulatory News (MGAM)

Share Price Information for Morgan Advanced Materials (MGAM)

Share Price is delayed by 15 minutes
Get Live Data
225.50    -3.50 (-1.53%)
Bid:
225.00
Ask:
225.50
Spread: 0.50 (0.222%)
Market Cap: £623.32m
MGAM Live PriceLast checked at - London Stock Exchange

Intraday Morgan Advanced Materials Share Chart

Director/PDMR Shareholding

24 Mar 2011 17:10

RNS Number : 6006D
Morgan Crucible Co PLC
24 March 2011
 



Notification of interests of directors/persons discharging managerial responsibility and connected persons ("PDMRs")

24th March 2011

This notification is made pursuant to DTR 3.1.4R (1)(a).

The Company announces that on 23rd March 2011 awards over ordinary 25p shares in the Company were made to the Directors and PDMRs listed below under the Company's Long Term Incentive Plan 2004 ("LTIP"). Subject to satisfaction of performance targets, awards under the LTIP will vest in three years' time. Except as described below in relation to Kevin Dangerfield and Peter Blausten (who have capacity within the £30,000 limit described below) the awards are structured as conditional awards of free shares.

Kevin Dangerfield and Peter Blausten each received an award structured as an Approved Performance Share Plan ("APSP") award. APSP awards under the LTIP comprise three elements: (i) an HM Revenue & Customs approved option over shares to the value of the first £30,000 worth of the award with an exercise price of 292.28 pence per share; (ii) an LTIP award in the form of a conditional award of free shares to the value of the remainder of the award above this limit; and (iii) a funding award, also in the form of a conditional award of free shares, over such number of shares whose value at exercise of the approved option equals £30,000. In addition to satisfaction of the performance targets, the approved option and the associated funding award will only vest in the event that the market value of a share at vesting is greater than 292.28 pence per share. The funding award is solely used to fund the exercise price of the approved option and will be satisfied by shares from the Company's employee benefit trust. Following vesting of the funding award, these shares are retained by the trust and not delivered to the participant. 

Name

Number of shares subject to award (approved option and LTIP award)

Maximum number of shares subject to funding award (not delivered to participant)

Mark Robertshaw

171,068

Nil

Kevin Dangerfield

90,666

6,481

Andrew Hosty

102,641

Nil

Peter Blausten

47,899

10,264

Paul Boulton

34,213

Nil

Spencer Evans

25,660

Nil

Simon Halliday

30,792

Nil

Don Klas

82,113

Nil

Andrew Riley

34,213

Nil

 

Following the grant of awards detailed above, the total number of shares in respect of which awards are held by those individuals pursuant to the Company's Long Term Incentive Plan are detailed below:

Name

Total Number of Shares held pursuant to LTIP awards

Mark Robertshaw

875,302

Kevin Dangerfield

498,801

Andrew Hosty

486,768

Peter Blausten

47,899

Paul Boulton

194,265

Spencer Evans

58,493

Simon Halliday

150,831

Don Klas

466,240

Andrew Riley

166,441

 

Enquiries: Tracey Bigmore, The Morgan Crucible Company plc

 

Tel: 01753 837000

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSLLFIDVTISFIL
Date   Source Headline
1st Jun 20264:35 pmRNSDirector/PDMR Shareholding
28th May 202610:10 amRNSHolding(s) in Company
26th May 20265:21 pmRNSDirector/PDMR Shareholding
18th May 20262:53 pmRNSHolding(s) in Company
13th May 20265:26 pmRNSHolding(s) in Company
12th May 20262:09 pmRNSDirector/PDMR Shareholding
7th May 20261:19 pmRNSResult of AGM
7th May 20267:00 amRNSCFO Intention to retire
7th May 20267:00 amRNSAGM Trading Update
29th Apr 20264:23 pmRNSDirector/PDMR Shareholding
9th Apr 20263:51 pmRNSHolding(s) in Company
31st Mar 20261:16 pmRNSDirector/PDMR Shareholding
26th Mar 20265:39 pmRNSDirector/PDMR Shareholding
26th Mar 20269:53 amRNSAnnual Financial Report
24th Mar 20262:44 pmRNSDirector/PDMR Shareholding
9th Mar 20269:34 amRNSDirector/PDMR Shareholding
5th Mar 20269:30 amRNSDirector/PDMR Shareholding
3rd Mar 20267:00 amRNSFull Year Results
23rd Feb 20269:00 amRNSHolding(s) in Company
2nd Feb 20264:12 pmRNSTotal Voting Rights
2nd Feb 20269:30 amRNSHolding(s) in Company
12th Jan 20267:00 amRNSTransaction in Own Shares
9th Jan 20267:00 amRNSTransaction in Own Shares
8th Jan 20267:00 amRNSTransaction in Own Shares
7th Jan 20267:00 amRNSTransaction in Own Shares
6th Jan 20267:00 amRNSTransaction in Own Shares
5th Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 202611:57 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 20267:00 amRNSTransaction in Own Shares
31st Dec 20257:00 amRNSTransaction in Own Shares
31st Dec 20257:00 amRNSTransaction in Own Shares
30th Dec 20257:00 amRNSTransaction in Own Shares
30th Dec 20257:00 amRNSTransaction in Own Shares
29th Dec 20257:00 amRNSTransaction in Own Shares
29th Dec 20257:00 amRNSTransaction in Own Shares
24th Dec 20257:00 amRNSTransaction in Own Shares
23rd Dec 20257:00 amRNSTransaction in Own Shares
23rd Dec 20257:00 amRNSTransaction in Own Shares
22nd Dec 202512:00 pmRNSBlock listing Interim Review
22nd Dec 202512:00 pmRNSBlock listing Interim Review
22nd Dec 20257:00 amRNSTransaction in Own Shares
22nd Dec 20257:00 amRNSTransaction in Own Shares
19th Dec 20257:00 amRNSTransaction in Own Shares
19th Dec 20257:00 amRNSTransaction in Own Shares
18th Dec 20257:00 amRNSTransaction in Own Shares
17th Dec 20257:00 amRNSTransaction in Own Shares
16th Dec 20257:00 amRNSTransaction in Own Shares
15th Dec 20257:00 amRNSTransaction in Own Shares
12th Dec 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.